Systematic review on thrombotic events in patients with COVID-19
DOI:
https://doi.org/10.31243/mdc.uta.v7i3.2074.2023Keywords:
COVID-19, thrombosis, coronavirus, clot, thrombotic eventsAbstract
Introduction: The novel coronavirus Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes systemic inflammations, bordering on the order of increasing proinflammatory cytokines. Objective: To determine thrombotic events and their impact on the clinical course of patients with COVID-19. Materials and methods: This observational, descriptive study used a bibliographic review of scientific studies; with the following inclusion criteria; English or Spanish language, with dissemination in the years 2020 and 2021, referring to thrombotic events. Results: As main result, 86.21% of conclusive results showed a positive relationship between the development of thrombotic events and higher severity index, being these: pulmonary embolism, venous thromboembolism, disseminated intravascular coagulation and arterial thrombosis. To recognize the clinical impact caused by these events in patients, the main biomarker that establishes clinical relevance with the prothrombotic state is D-dimer, suggesting its sequential monitoring.
Conclusion: There is a positive association between thrombotic events and the aggravated clinical course of COVID-19 disease, with progression to severity in up to 93.10% of patients who develop thrombotic events.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Mediciencias UTA
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
